US Patent Issued to Gan & Lee Pharmaceuticals on Oct. 27 for "Insulin derivative" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,443, issued on Oct. 27, was assigned to Gan & Lee Pharmaceuticals Co. Ltd. (Beijing).

"Insulin derivative" was invented by Zhongru Gan (Beijing), Wei Chen (Beijing), Yining Zhang (Beijing), Fangkai Xue (Beijing), Lingyu Cai (Beijing), Jianghong Niu (Beijing) and Bin Mu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel insulin derivative, a pharmaceutical formulation thereof, a pharmaceutical composition thereof with a long-acting GLP-1 compound and medical use of the insulin derivative, the pharmaceutical formulation and the pharmaceutical composition. The novel acylated insulin has surprisingly and sig...